Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it enclosed the schedule of the Analyst/ Institutional Investor Meetings with the Company as on 24th May 2023 and 25th May 2023. More details enclosed.
The above information is a part of company’s filings submitted to BSE.